AM630 is an inverse agonist at the human cannabinoid CB1 receptor

被引：46

作者：

Landsman, RS

Makriyannis, A

Deng, HF

Consroe, P

Roeske, WR

Yamamura, HI ^{[1
]}

机构：

[1] Univ Arizona, Hlth Sci Ctr, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA

[2] Univ Arizona, Hlth Sci Ctr, Dept Pharmacol & Toxicol, Tucson, AZ 85724 USA

[3] Univ Arizona, Hlth Sci Ctr, Dept Biochem, Tucson, AZ 85724 USA

[4] Univ Arizona, Hlth Sci Ctr, Dept Med, Tucson, AZ 85724 USA

[5] Univ Arizona, Hlth Sci Ctr, Dept Psychiat, Tucson, AZ 85724 USA

[6] Univ Arizona, Hlth Sci Ctr, Program Neurosci, Tucson, AZ 85724 USA

[7] Univ Connecticut, Sch Pharm, Storrs, CT 06269 USA

来源：

LIFE SCIENCES | 1998年 / 62卷 / 09期

关键词：

human cannabinoid CB1 receptor; inverse agonism; AM630; WIN 55,212-2; GTP gamma S; CHO cells; inverse agonist; negative intrinsic activity;

D O I：

10.1016/S0024-3205(97)01187-9

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

The present investigation examines WIN 55,212-2 and AM630 at the cloned human cannabinoid CB1, receptor stably expressed in Chinese hamster ovary (CHO) cells. The effect of various concentrations of WIN 55,212-2 and AM630 on basal [S-35]GTP gamma S binding to cell membranes was determined. WIN 55,212-2 (100 mu M) stimulated basal [S-35]GTP gamma S binding 77.9% with an EC50 value of 0.36 mu M. Conversely, AM630 (100 mu M) inhibited basal [S-35]GTP gamma S binding by 20.9% with an EC50 value of 0.90 mu M These results show that WIN 55,212-2 is an agonist and AM630 is an inverse agonist in this system. (C) 1998 Elsevier Science Inc.

引用

页码：PL109 / PL113

页数：5

共 50 条

[31] THE EFFECTS OF THE CANNABINOID CB2 RECEPTOR ANTAGONIST, AM630, ON ISOLATION REARING-INDUCED BEHAVIOURAL DEFICITS IN RATS
Khan, Asma
Kendall, David A.
Fone, Kevin C. F.
SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 391 - 392
[32] The interactive effects of verapamil and CB1 cannabinoid receptor antagonist/inverse agonist, AM251 on passive avoidance learning and memory in rat
Karimi, Seyed Asaad
Noorbakhsh, Mariam
Komaki, Hamidreza
Nikoo, Mohammad Reza
Hasanein, Parisa
Shahidi, Siamak
Faraji, Nafiseh
Komaki, Alireza
BEHAVIOURAL PHARMACOLOGY, 2022, 33 (2-3): : 222 - 229
[33] Effects of the CB1 cannabinoid receptor inverse agonist AM251 on food intake and body weight in mice lacking μ-opioid receptors
Chen, Richard Z.
Frassetto, Andrea
Fong, Tung M.
BRAIN RESEARCH, 2006, 1108 : 176 - 178
[34] The novel cannabinoid CB1 receptor agonist AM11101 increases food intake in female rats
Ogden, Sean B.
Malamas, Michael S.
Makriyannis, Alexandros
Eckel, Lisa A.
BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (20) : 3972 - 3982
[35] The CB1 cannabinoid receptor in the brain
Howlett, AC
NEUROBIOLOGY OF DISEASE, 1998, 5 (06) : 405 - 416
[36] Cannabinoid CB1 Receptor Antagonists
Thomas, Brian F.
DRUG DEVELOPMENT RESEARCH, 2009, 70 (08) : 525 - 526
[37] CB1 cannabinoid receptor ligands
Thakur, GA
Nikas, SP
Makriyannis, A
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (07) : 631 - 640
[38] CB1 cannabinoid receptor antagonists
Barth, F
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 40, 2005, 40 : 103 - 118
[39] The Cannabinoid CB1 Receptor in Schizophrenia
Borgan, Faith
Kokkinou, Michelle
Howes, Oliver
BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING, 2021, 6 (06) : 646 - 659
[40] Inverse agonist effects of the cannabinoid CB1 receptor antagonist SR141716A in rat brain.
Sim-Selley, LJ
Brunk, LK
Selley, DE
FASEB JOURNAL, 2000, 14 (08): : A1447 - A1447

← 1 2 3 4 5 →